CMMB Stock Price and Chart — NASDAQ:CMMB — TradingView

Peers for comparison

Key stats

Upcoming earnings

Company info

Chemomab Therapeutics Ltd. is a clinical-stage biotech company, which engages in the provision of therapeutics for conditions with unmet need that involve Inflammation and fibrosis. The company was founded by Adi Mor on September 22, 2011 and is headquartered in Tel Aviv, Israel.

Financials

Performance

Revenue to profit conversion

Debt level and coverage

Earnings

Next:—

Ideas

Pre-Market Update: CMMB - Breakout on News Overview Looking for an incoming buy-in opportunity on APO - Apollo around the $158-$160 range by mid-February. This setup aligns with a potential longer-term hold and a continuation back to its previous all-time highs (ATHs). If it follows an incremental climb higher, this could yield a 19-20%+ gai

CMMB double bottom supply line test might end up in a breakout If it can hold the double bottom, it can play out the divergence and push upwards.

CMMB Chemomab Therapeutics Ltd (NASDAQ:CMMB) My opinion remains intact about this small bio cap. I will not sell a single share below $40 unless something bad happens, but that does not seem to be the case according to the recent news and reports. The stock has been falling on very low volume. The compan

CMMB Chemomab Therapeutics Ltd (NASDAQ:CMMB) With Friday’s breakout movement above 18 on decent volume, the downtrend is over. A break higher above the recent highs 19.35 would help the stock move to the $22.75-$24 area. Momentum indicators are turning up, a positive sign.

CMMB Chemomab Therapeutics Ltd (NASDAQ:CMMB) My long position on this small bio play remains intact. On the technical side, the stock has been pulling back on low volume to test the breakout zone around the $20 area. If this zone is respected next week, I expect that the next rebound will push the price

CMMB I think Chemomab Therapeutics Ltd (NASDAQ:CMMB) is building a nice base for take off. Some technical indicators are showing positive divergences on a daily basis. We could be in the early stages of a nice rally for this stock. Keep a close eye on it going forward. The stock currently trades at just

Short Squeeze - CMMB Idea for Chemomab Therapeutics Ltd.: - 131% borrow fee for shares. 47 shares available for borrow, according to iborrowdesk. - Bottom of Risk Range: - S3 Filing Sales Agreement with Cantor Fitzgerald & Co. dated Apr 30, 2021. fintel.io - Cantor Fitzgerald assigned overweight rating on CMMB and r

by UnknownUnicorn1043646

CMMB I've mentioned Chemomab Therapeutics Ltd (NASDAQ:CMMB) for the bulls out there. On Friday, Oppenheimer initiated coverage on the stock with an Outperform rating and announced a price target of $42 per share. It seems that analysts are also seeing what I'm seeing, a stock trading at bargain prices wi

CMMB Chemomab Therapeutics Ltd (NASDAQ:CMMB) This is a stock that I like a lot for another big rally. In the last couple of times it went under $30, the stock had a big spike right after. Don't worry with the SEC Form S-3 filed on Friday, for me means news ahead, before the raise ;) read the market behin

Anchiano and Chemomab merge, 16:1 reverse split $CMMB = New $ANCN Chemomab just merged with Anchiano There was a 16:1 reverse split on ANCN shares last nigth as part of the merger

by augustincloutier

See all ideas

Technicals

Summarizing what the indicators are suggesting.

Oscillators

Neutral

Oscillators

Neutral

Summary

Neutral

Summary

Neutral

Summary

Neutral

Moving Averages

Neutral

Moving Averages

Neutral

Seasonals

Displays a symbol's price movements over previous years to identify recurring trends.